DNAnexus

DNAnexus

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $256M

Overview

DNAnexus is a leading provider of a cloud-based data platform specifically designed for the precision health and genomics sector. Founded in 2009, the company offers an enterprise-grade solution that allows pharmaceutical companies, diagnostic providers, research institutions, and biobanks to securely manage, analyze, and derive insights from complex multiomic and clinical data at scale. The platform emphasizes regulatory compliance, AI integration, and operational efficiency, positioning DNAnexus as a critical infrastructure partner in the growing field of data-driven biomedical research. It is a private company trusted by major industry players to accelerate the translation of genomic data into scientific breakthroughs and improved patient outcomes.

Genetics & GenomicsAI / Machine LearningDigital Health

Technology Platform

The DNAnexus Precision Health Data Cloud: A secure, compliant cloud platform for managing, analyzing, and collaborating on multimodal and multiomic data. It integrates workflow execution (Nextflow, WDL), AI/ML tools, cohort browsers, JupyterLab, and visualization apps within a framework compliant with GxP, HIPAA, GDPR, and other major regulations.

Funding History

5
Total raised:$256M
Series E$100M
Series D$68M
Series C$58M
Series B$15M

Opportunities

The exponential growth of multiomic data and the integration of AI into life sciences create a massive demand for specialized, secure, and compliant data platforms.
DNAnexus is poised to capture market share as a neutral, trusted infrastructure layer enabling precision medicine from research to point-of-care, especially through strategic partnerships that bridge genomic data with clinical health records.

Risk Factors

Faces competition from large hyperscale cloud providers offering generic genomics services and other bioinformatics software companies.
Bears significant and ongoing risk related to cybersecurity and the complexity of maintaining compliance with a vast array of global health data regulations (GxP, HIPAA, GDPR).
Growth is dependent on sustained R&D investment across the biopharma and research sectors.

Competitive Landscape

DNAnexus competes in the bioinformatics cloud platform space against broad cloud providers like AWS (Amazon Genomics CLI), Google Cloud (Life Sciences API), and Microsoft Azure (Azure Health Data Services) as well as other specialized players like Seven Bridges, Illumina's BaseSpace, and Partek Flow. Its differentiation lies in its deep focus on enterprise-grade security, pre-validated regulatory compliance, and a platform specifically architected for the end-to-end needs of precision health organizations.